Mark Dumenil was born in London. Mark moved to France in 1981 and directed his career to international healthcare with a particular interest in introducing medical devices technology that make a difference to patients’ lives across Europe.
With nearly 30 years’ experience in a variety of international leadership roles at CR Bard Inc. Johnson and Johnson Inc. and CMA Microdialysis AB, Mark has developed strong connections with leading clinical, regulatory and well as market access specialists across Europe.
In 1996 Mark joined the Ethicon Division of J&J and was offered a leadership role in developing a new surgical oncology business. This was later merged with urology where he was made Vice President Europe for Oncology and Urology.
Today he leads an international healthcare consultancy based in Paris dedicated to introducing successfully promising medical technologies across Europe and lives between France and the UK.